PURCHASE ORDER
Active75D30126P21232
Department of Health and Human Services › Centers for Disease Control and Prevention › CDC OFFICE OF ACQUISITION SERVICES
$122K
obligated · signed 2 months ago
EO 14398: NOVAPLEX SYSTEM
Performance timeline
Start
Aug 6, 2026
End
Jun 14, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jun 14, 2027
SEEGENE USA, INC.
Contract 75D30126P21232
UEI
YDDKWNE9JAY7
Parent Company
SEEGENE USA, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 47
Current Obligation
$121,950
Base + Exercised Options
$121,950
Total Ceiling Value
$121,950
Contract Type
FIRM FIXED PRICE
NAICS
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Place of Performance
Congressional District: 47
Awarding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Funding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Solicitation procedures, competition exceptions, labor standards and account totals.